XML 109 R92.htm IDEA: XBRL DOCUMENT v3.25.4
Variable Interest Entities - Schedule of Operating Results (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Variable Interest Entity [Line Items]      
Revenues $ 5,932,576 $ 6,060,530 $ 4,316,363
Income (loss) from operations (463,236) (292,130) (232,133)
Net income (loss) (391,347) (260,151) (262,596)
Other income (expense), net 67,616 34,489 27,840
Equity Method Investment, Nonconsolidated Investee or Group of Investees      
Variable Interest Entity [Line Items]      
Income (loss) from operations (5,032) 22,687 22,500
Net income (loss) (1,824) 15,050 16,336
Physician compensation expense 58,900 58,400 53,700
Physician compensation expense, exchange for common stock     15,200
Equity Method Investment, Nonconsolidated Investee or Group of Investees | CMS ACO Models      
Variable Interest Entity [Line Items]      
Revenues 3,500 3,900 1,600
Other income (expense), net 50,100 14,900 2,900
Medical services revenue      
Variable Interest Entity [Line Items]      
Revenues 5,921,341 6,047,715 4,307,350
Expenses (5,977,906) (5,842,530) (4,008,659)
Medical services revenue | Equity Method Investment, Nonconsolidated Investee or Group of Investees      
Variable Interest Entity [Line Items]      
Revenues 1,693,036 1,814,618 1,160,978
Expenses (1,539,486) (1,667,806) (1,024,468)
Other operating revenue      
Variable Interest Entity [Line Items]      
Revenues 11,235 12,815 9,013
Expenses (114,691) (213,159) (238,034)
Other operating revenue | Equity Method Investment, Nonconsolidated Investee or Group of Investees      
Variable Interest Entity [Line Items]      
Expenses $ (90,501) $ (89,788) $ (96,154)